Our findings suggest that the ccf-mtDNA may act as a critical signaling molecule in chronic inflammation via AIM2 inflammasome activation in metabolic diseases, including type 2 diabetes. The gene discussed is PITX1; the disease is type 2 diabetes mellitus.